Unknown PHASE2 INTERVENTIONAL 7-arm NCT02498782

Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease

Phase 2, Randomized, Multicenter, Placebo-controlled, Safety and Efficacy Study to Evaluate Six Oral Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chronic Indeterminate Chagas Disease.

Sponsor: Drugs for Neglected Diseases

Conditions Chagas Disease Disease, Chagas South American Trypanosomiasis Trypanosomiasis, South American

Interventions Fexinidazole Placebo

Updated 6 times since 2017 Last updated: Jul 14, 2015 Started: Jul 31, 2014 Primary completion: Sep 30, 2015 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Chagas Disease and Disease, Chagas, this trial is ongoing. The trial is conducted by Drugs for Neglected Diseases and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Aug 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Recruiting PHASE2

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Drugs for Neglected Diseases

Data source: Drugs for Neglected Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cochabamba, Bolivia
• Tarija, Bolivia